The SAM soft tissue anchors market is expected to grow from US$30.09 million in 2022 to US$ 38.59 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2022 to 2028.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM soft tissue anchors market . The SAM soft tissue anchors market is expected to grow at a good CAGR during the forecast period.
Based on typing type, the market is bifurcated into knotted & knotless. The knotless segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
Based on material, the market is segmented into metallic suture anchor, bioabsorbable suture anchor, PEEK suture anchor, bio-composite suture anchor, and others. The PEEK suture anchor segment dominated the market in 2022 and bio-composite suture anchor is expected to be fastest growing during forecast period.
Based on end user, the market is segmented into hospitals, clinics, emergency medical services, and others. The emergency medical services segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
Based on country, the SAM soft tissue anchors market is segmented into Brazil, Argentina, and Rest of SAM.
Aju Pharm Co., Ltd.; Arthrex, Inc.; CONMED Corporation; Cook Medical LLC; DJO, LLC (Colfax Corporation); Johnson & Johnson Services, Inc. (DePuy Synthes); Medtronic; Smith & Nephew Plc.; Stryker Corporation; and Zimmer Biometare among the leading companies in the SAM soft tissue anchors market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM soft tissue anchors market . The SAM soft tissue anchors market is expected to grow at a good CAGR during the forecast period.
SAM Soft Tissue Anchors Market Segmentation
The SAM soft tissue anchors market is segmented on the basis of type, typing type, material, end user and country. Based on type, the market is segmented into absorbable and non-absorbable. The absorbable segment dominated the market in 2022 and is expected to be fastest growing during forecast period.Based on typing type, the market is bifurcated into knotted & knotless. The knotless segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
Based on material, the market is segmented into metallic suture anchor, bioabsorbable suture anchor, PEEK suture anchor, bio-composite suture anchor, and others. The PEEK suture anchor segment dominated the market in 2022 and bio-composite suture anchor is expected to be fastest growing during forecast period.
Based on end user, the market is segmented into hospitals, clinics, emergency medical services, and others. The emergency medical services segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
Based on country, the SAM soft tissue anchors market is segmented into Brazil, Argentina, and Rest of SAM.
Aju Pharm Co., Ltd.; Arthrex, Inc.; CONMED Corporation; Cook Medical LLC; DJO, LLC (Colfax Corporation); Johnson & Johnson Services, Inc. (DePuy Synthes); Medtronic; Smith & Nephew Plc.; Stryker Corporation; and Zimmer Biometare among the leading companies in the SAM soft tissue anchors market.
Table of Contents
1. Introduction
3. Research Methodology
4. SAM Soft Tissue Anchors Market - Market Landscape
5. SAM Soft Tissue Anchors Market- Key Market Dynamics
6. Soft Tissue Anchors Market- SAM Analysis
7. SAM Soft Tissue Anchors Market Analysis - By Type
8. SAM Soft Tissue Anchors Market Analysis - By Tying Type
9. SAM Soft Tissue Anchors Market Analysis - By Material
10. SAM Soft Tissue Anchors Market - By End User
11. SAM Soft Tissue Anchors Market Revenue and Forecasts to 2028 - Country Analysis
12. SAM Soft Tissue Anchors Market-Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aju Pharm Co., Ltd.
- Arthrex, Inc.
- CONMED Corporation
- DJO, LLC (Colfax Corporation)
- Johnson & Johnson Services, Inc. (DePuy Synthes)
- Medtronic
- Smith & Nephew Plc.
- Stryker Corporation
- Zimmer Biomet
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 134 |
| Published | October 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 30.09 Million |
| Forecasted Market Value ( USD | $ 38.59 Million |
| Compound Annual Growth Rate | 4.2% |
